A032302 Docetaxel Addition in mCRPC (ASPIRE)

A032302 Docetaxel Addition in mCRPC (ASPIRE)

Es posible que algunos contenidos no estén disponibles en español.

Study Details

Full Title

Protocol A032302 Docetaxel Addition in Metastatic Castrate-Sensitive Prostate Cancer (ASPIRE)

Principal Investigator

Hannah
McManus

Protocol Number

PRO00119563

NCT ID

NCT06931340

Phase

III

Enrollment Status

Open to Enrollment
ClinicalTrials.gov